The investigation determined that false positive vitros rub g results were obtained from a single patient sample when tested using vitros rub g lot 2210 on a vitros 5600 integrated system.A definitive assignable cause of the event was not established.A vitros rub g lot 2210 reagent issue cannot be ruled out as a contributor to the event.There was insufficient quality control data to verify vitros rub g reagent assay performance and the customer used a quality control fluid not recommended by ortho for use to verify vitros rub g performance a day prior to the event.However, ongoing tracking and trending of complaint data has not identified any signals to suggest there is a systemic quality issue with vitros rub g lot 2210.Additionally, an instrument issue cannot be ruled out as a contributor to the event, as precision testing was not conducted to verify the performance of the vitros 5600 integrated system.The customer was not following the manufacturer¿s recommendations for collection device handling.Improper pre-analytical sample handling could have contributed to this event.It is possible that cellular debris, due to poor sample preparation, was present in the affected sample, although this could not be confirmed.A patient sample handling and storage issue cannot be ruled out as a contributor to the event.The patient sample was stored interchangeably between 2-8 c and -20 c storage since collection on (b)(6) 2020 and the false positive vitros rub g results that were obtained on (b)(4) 2020 and (b)(4) 2020 respectively, meaning the sample was outside the recommended storage.The vitros rub g instructions for use states that serum and plasma samples may be stored for up to 7 days at 2¿8 °c and to avoid repeated freeze-thaw cycles.Interference from a non-specific antibody has been ruled out as a contributor to the event, as the vitros rub g result from testing using a non-specific antibody blocking tube (nabt) was similar to the initial, untreated vitros rub g result for the patient.
|